Skip to main content
. 2020 Aug 25;93(3):1449–1458. doi: 10.1002/jmv.26424

Table 1.

Demographic and clinical characteristics of COVID‐19 patients

Number (N) of studies Number (n) of study population Valuea 95% CI
Demographics
Mean age, y 88 8908 46.7 42.8‐50.6
Male (%) 168 17 1689 51.9 50.4‐53.2
Female (%) 164 17 1034 48.95 47.5‐50.4
Clinical presentation
Onset
Time from illness onset to first hospital admission, d 26 3508 5.5 4.6‐6.4
Incubation period, d 7 746 5.3 4.5‐5.99
General
Fever (%) 156 15 921 78.8 76.2‐81.3
Chills (%) 28 4430 15.7 12.3‐19.7
Fatigue (%) 99 13 680 32.2 28.0‐36.6
Myalgia (%) 78 10 728 21.3 18.1‐24.9
Malaise (%) 39 2526 37.9 29.5‐47.1
Respiratory
Cough (%) 119 12 782 53.9 50.0‐57.7
Expectoration (%) 61 8748 24.2 21.0‐27.8
Rhinorrhea (%) 43 6072 7.5 5.7‐9.6
Chest pain (%) 32 3512 9.0 6.2‐13.1
Shortness of breath (%) 82 11 205 18.99 15.7‐22.8
Gastrointestinal
Vomiting (%) 48 7484 4.7 3.8‐5.8
Abdominal pain (%) 23 3350 4.5 3.3‐6.2
Diarrhea (%) 94 12 149 9.5 7.8‐11.5
Anorexia (%) 30 3610 13.99 10.4‐18.5
Nausea (%) 38 5599 6.96 5.3‐9.1
Neurological
Dizziness (%) 24 2350 9.4 7.1‐12.4
Headache (%) 76 12 382 9.7 8.3‐11.3
Comorbidities
Malignancy (%) 47 8733 3.3 2.6‐4.3
Chronic heart disease (%) 52 82 217 7.9 4.9‐12.6
Chronic renal disease (%) 32 81 471 2.8 1.2‐6.1
Chronic lung disease (%) 30 78 691 4.0 2.3‐6.95
Chronic liver disease (%) 32 79 525 3.3 1.7‐6.3
Diabetes (%) 71 84 469 10.2 7.4‐13.9
Hypertension (%) 74 9937 19.4 17.3‐21.6
Clinical course and outcomes
Intensive care unit 39 80 487 10.96 6.6‐17.6
Mortality (%) 86 52 808 5.6 4.2‐7.5
Shock (%) 13 2985 4.3 2.3‐7.9
Mechanical ventilation (%) 36 6152 7.1 4.5‐11.0
Hepatic injury (%) 13 77 331 7.9 2.6‐21.7
Renal injury (%) 17 77 679 3.6 1.2‐10.1
Cardiac injury (%) 10 1417 9.4 4.5‐18.8

Abbreviations: CI, confidence interval; COVID‐19, coronavirus disease 2019.

a

Value expressed as mean or %.